Revenue grew 35% year-over-year to €2.3 million, with improved profitability and a strong €60 million liquidity position. Expansion continued in key markets, new labs were established, and commercial launches are imminent in Singapore and the U.S.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.